![How Technology Is Solving Key Challenges in the Clinical Lab](https://www.g2intelligence.com/wp-content/uploads/2023/03/Apr23.DTET_.ClinicalLabTrendsLeanneDavey-Q-and-A-iStock-1800x1250-1-1080x675.jpg)
How Technology Is Solving Key Challenges in the Clinical Lab
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.
Lab leaders must be able to make a sound assessment of both the costs and benefits, and the liability risks involved.
Labs have a duty to inquire into what their billing company is up to and whether it complies with all applicable regulations.
Recent Advisory Opinion sheds light on offering patients financial assistance so they can receive the provider’s products and services.
A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.